Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism

1Department of Physical Medicine and Rehabilitation, Medical Faculty of Ankara University, Division of Rheumatology, Ankara, Turkey; 2Department of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey; 3Department of Therapy and Rehabilitation, Ankara University, Haymana Vocational School, Ankara, Turkey; 4Department of Physical Medicine and Rehabilitation, Medical Faculty of Yeditepe University, Istanbul, Turkey; 5Department of Physical Medicine and Rehabilitation, Medical Faculty of Ankara University, Ankara, Turkey; 6Department of Physical Medicine and Rehabilitation, Ankara Numune Education and Research Hospital, Ankara, Turkey; 7Department of Physical Medicine and Rehabilitation, Medical Faculty of Inonu University, Malatya, Turkey; 8Department of Physical Medicine and Rehabilitation, Medical Faculty of Trakya University, Edirne, Turkey; 9Department of Physical Medicine and Rehabilitation, Medical Faculty of Akdeniz University, Division of Rheumatology, Antalya, Turkey; 10Department of Physical Medicine and Rehabilitation, Medical Faculty of Celal Bayar University, Division of Rheumatology, Manisa, Turkey; 11Department of Physical Medicine and Rehabilitation, Medical Faculty of Gazi University, Division of Rheumatology, Ankara, Turkey; 12Department of Physical Medicine and Rehabilitation, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey; 13Department of Physical Medicine and Rehabilitation, Van Training and Research Hospital, Division of Rheumatology, Van, Turkey; 14Department of Physical Medicine and Rehabilitation, Medical Faculty of Cumhuriyet University, Division of Rheumatology, Sivas, Turkey; 15Department of Physical Medicine and Rehabilitation, Izmir Ataturk Training and Research Hospital, Izmir, Turkey; 16Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, Istanbul, Turkey; 17Department of Physical Medicine and Rehabilitation, Medical Faculty of Bezmialem Vakif University, Istanbul, Turkey; 18Department of Physical Medicine and Rehabilitation, Medical Faculty of Suleyman Demirel University, Isparta, Turkey; 19Department of Physical Medicine and Rehabilitation, Medical Faculty of Erciyes University, Division of Rheumatology, Kayseri, Turkey;

• Publication year

  2011

• Venue

  Archives of Rheumatology

• Publication date

  2011-12-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.5606/TJR.2011.046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Rheumatoid Arthritis

  2012cited by this paper
• An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis.

  2012cited by this paper
• Quality appraisal of clinical practice guidelines on the use of physiotherapy in rheumatoid arthritis: a systematic review.

  2011influential reference
• Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

  2011cited by this paper
• The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

  2011cited by this paper
• Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review

  2011cited by this paper
• Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)

  2011cited by this paper
• [Combination therapy using methotrexate with DMARDs or biologics--current status].

  2011cited by this paper
• Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller Stand

  2011cited by this paper
• Arthritis patient education and team approaches to management

  2011cited by this paper
• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  2011cited by this paper
• Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

  2011cited by this paper
• Do biologics-naïve patients with rheumatoid arthritis respond better to tocilizumab than patients for whom anti-TNF agents have failed? A retrospective study.

  2011cited by this paper
• Adverse effects of biologics: a network meta-analysis and Cochrane overview.

  2011cited by this paper
• Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

  2011cited by this paper
• Treatment of early rheumatoid arthritis: concepts in management.

  2011cited by this paper
• Biologics in rheumatoid arthritis--recommendations for Swiss practice.

  2011cited by this paper
• The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

  2011cited by this paper
• Cost-Effectiveness of Combination Nonbiologic Disease-Modifying Antirheumatic Drug Strategies in Patients with Early Rheumatoid Arthritis

  2011cited by this paper
• Update 2011: leflunomide in rheumatoid arthritis – strengths and weaknesses

  2011cited by this paper
• Disease‐modifying anti‐rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community‐based practice

  2011cited by this paper
• Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register

  2011cited by this paper
• Re: European Commission Consultation on the Eu Corporate Governance Framework Com(2011) 164

  2011cited by this paper
• Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

  2011cited by this paper
• Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

  2010cited by this paper
• Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

  2010cited by this paper
• Drug combinations with methotrexate to treat rheumatoid arthritis.

  2010cited by this paper
• Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

  2010cited by this paper
• Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics

  2010cited by this paper
• Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy.

  2010cited by this paper
• Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

  2010cited by this paper
• Self-management of rheumatic diseases: state of the art and future perspectives

  2010cited by this paper
• A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

  2010cited by this paper
• Treating rheumatoid arthritis to target: recommendations of an international task force

  2010cited by this paper
• Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology

  2010cited by this paper
• Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

  2010cited by this paper
• Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

  2010cited by this paper
• Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion.

  2010cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010influential reference
• Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

  2010cited by this paper
• Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis

  2010cited by this paper
• Low‐dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy

  2010cited by this paper
• Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission

  2010cited by this paper
• Use of glucocorticoids in rheumatoid arthritis - pratical modalities of glucocorticoid therapy: recommendations for clinical practice based on data from the literature and expert opinion.

  2010cited by this paper
• Effectiveness of two finger splints for swan neck deformity in patients with rheumatoid arthritis: a randomized, crossover trial.

  2009cited by this paper
• Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

  2009cited by this paper
• Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

  2009cited by this paper
• Non-drug therapies in early rheumatoid arthritis.

  2009cited by this paper
• Systemic effects of intra-articular corticosteroids

  2009cited by this paper
• Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

  2009cited by this paper
• Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.

  2009cited by this paper
• Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis.

  2009cited by this paper
• Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

  2009cited by this paper
• Compendium on Rheumatic Diseases

  2009cited by this paper
• Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.

  2009cited by this paper
• The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.

  2009cited by this paper
• Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines.

  2009influential reference
• Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

  2009cited by this paper
• Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

  2009cited by this paper
• Rheumatoid Atlantoaxial Subluxation Can Be Prevented by Intensive Use of Traditional Disease Modifying Antirheumatic Drugs

  2009cited by this paper
• Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

  2009cited by this paper
• A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.

  2009cited by this paper
• Developments in the clinical understanding of rheumatoid arthritis

  2009cited by this paper
• Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature.

  2009cited by this paper
• Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008

  2009cited by this paper
• Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists.

  2008cited by this paper
• Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

  2008cited by this paper
• European biologicals registers: methodology, selected results and perspectives

  2008cited by this paper
• Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

  2008cited by this paper
• Rehabilitation in musculoskeletal diseases.

  2008cited by this paper
• Are biologics more effective than classical disease-modifying antirheumatic drugs?

  2008influential reference
• Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

  2008cited by this paper
• Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

  2008cited by this paper
• Induction of remission in rheumatoid arthritis: criteria and opportunities

  2008cited by this paper
• Efficacy of wrist working splints in patients with rheumatoid arthritis: a randomized controlled study.

  2008cited by this paper
• Effectiveness of a night-time hand positioning splint in rheumatoid arthritis: a randomized controlled trial.

  2008cited by this paper
• Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis

  2008cited by this paper
• Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.

  2008cited by this paper
• Custom-made foot orthoses for the treatment of foot pain.

  2008cited by this paper
• Developing multidisciplinary guidelines for the management of early rheumatoid arthritis.

  2008cited by this paper
• The clinical effectiveness of static resting splints in early rheumatoid arthritis: a randomized controlled trial.

  2008cited by this paper
• Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

  2007cited by this paper
• Non-drug care for RA--is the era of evidence-based practice approaching?

  2007influential reference
• High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study

  2007cited by this paper
• Effects of an educational–behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial

  2007cited by this paper
• National institute for Health and Clinical excellence guidance

  2007cited by this paper
• Effectiveness of Nonpharmacological and Nonsurgical Interventions for Patients With Rheumatoid Arthritis: An Overview of Systematic Reviews

  2007cited by this paper
• Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score

  2007cited by this paper
• Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

  2007cited by this paper
• British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

  2007cited by this paper
• Non-drug care for RA—is the era of evidence-based practice approaching?

  2007cited by this paper
• Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

  2007cited by this paper
• Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

  2007cited by this paper
• Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

  2007cited by this paper
• Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis

  2007cited by this paper
• Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.

  2007cited by this paper
• British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).

  2006cited by this paper
• Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

  2006cited by this paper
• A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

  2006cited by this paper
• Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.

  2006cited by this paper

• Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme

  2021cites this paper
• A systematic review of guidelines for managing rheumatoid arthritis

  2019cites this paper
• Spa therapy adjunct to pharmacotherapy is beneficial in rheumatoid arthritis: a crossover randomized controlled trial

  2018cites this paper
• “Official View” on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements

  2017influential citation
• Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National Registry.

  2016cites this paper
• Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR

  2015cites this paper
• Периоперационное ведение больных ревматоидным артритом

  2014cites this paper
• Is There An Association Between Two-STAT4 Gene Polymorphisms and Rheumatoid Arthritis in Turkish Population?

  2014cites this paper
• Rehabilitative Approach to Rheumatological Diseases

  2013cites this paper
• Agreement of Turkish Physiatrists with the Assessment in Spondyloarthritis International Society and the European League Against Rheumatism Recommendations for the Management of Ankylosing Spondylitis and Rheumatoid Arthritis

  2012cites this paper